The Cooper Companies, Inc. logo

The Cooper Companies, Inc.

TickerCOOVenueUSSectorHealthcarePrimary listingBeta0.82
$58.16+0.38%
FinScore61

The Cooper Companies, Inc. is a United States-based company in the Healthcare sector with a market capitalisation of $11.1B. Its FinScore is 61/100; its highest-scoring layer is Value (68) and its lowest is Momentum (36). The shares trade at 19.3x trailing earnings and are down 29% year to date.

Market cap
$11.1B
P/E (TTM)
19.3x
ROE
6.9%

Share price performance

Loading chart…

About The Cooper Companies, Inc.

www.coopercos.com

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

Profile
Sector
Healthcare
Industry
Medical - Instruments & Supplies
HQ
United States
Fiscal year-end
October
Trading currency
USD
Reporting currency
USD
Fundamentals updated
7 days ago
Market
Market cap
$11.1B
Shares outstanding
190.2M
P/E (TTM)
19.3x
Beta (issuer)
0.82
Revenue (latest FY)
$4.1B

Revenue breakdown

FY 2025$4.1B
  • Coopervision Segment
    67.0%$2.7B
  • Coopersurgical Segment
    33.0%$1.3B

FinScore

As of 2026-10-19
Overall61
Quality65
Growth56
Value68
Momentum36
Relative Strength76

Snapshot

Ownership

As of 2026-06-30
Institutional
100.0%
Insider
0.1%
Free float
99.4%
Top-5 institutional holders
27.1%
Shares outstanding
190.2M
Sign up to see the top holders

Sign up or log in to see Analysis

Analysis for The Cooper Companies, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for The Cooper Companies, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for The Cooper Companies, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for The Cooper Companies, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for The Cooper Companies, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for The Cooper Companies, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.